Recruiting Narcolepsy Type 1 Studies in Colorado Springs
About Narcolepsy Type 1 Clinical Trials in Colorado Springs
Narcolepsy type 1 is characterized by excessive daytime sleepiness and sudden loss of muscle tone (cataplexy), caused by loss of hypocretin-producing neurons in the brain. It affects about 1 in 2,000 people. Treatment includes stimulants, sodium oxybate, and newer orexin receptor agonists.
There are currently 1 narcolepsy type 1 clinical trials recruiting participants in Colorado Springs, CO. These studies are seeking a combined 222 participants. Research is being sponsored by Centessa Pharmaceuticals (UK) Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Narcolepsy Type 1 Clinical Trials in Colorado Springs — FAQ
Are there narcolepsy type 1 clinical trials in Colorado Springs?
Yes, there are 1 narcolepsy type 1 clinical trials currently recruiting in Colorado Springs, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Colorado Springs?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.
Are clinical trials in Colorado Springs free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.
What narcolepsy type 1 treatments are being tested?
The 1 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy type 1.
Data updated October 15, 2026 from ClinicalTrials.gov